HENRY COLCHER, M.D.; STANLEY R. DRACHMAN, M.D.; DAVID ADLERSBERG, M.D., F.A.C.P.
In a previous communication,1a observations on the clinical and chemical effects of cortisone and ACTH in the sprue syndrome were reported. Independently, similar observations by other authors1b, 1c have been published. Of the five patients with primary sprue studied by us, four proved to be resistant to the conventional forms of therapy prior to the use of these hormones.1a It is the purpose of this paper to report the results of prolonged treatment and certain additional observations made in the past 18 months. The group studied consisted of the above five patients and three others.
The eight patients
COLCHER H, DRACHMAN SR, ADLERSBERG D. MANAGEMENT OF INTRACTABLE SPRUE WITH CORTISONE AND ADRENOCORTICOTROPIN (ACTH)(MANAGEMENT OF INTRACTABLE SPRUE WITH CORTISONE AND ADRENOCORTICOTROPIN (ACTH)*). Ann Intern Med. 1953;38:554–567. doi: 10.7326/0003-4819-38-3-554
Download citation file:
Published: Ann Intern Med. 1953;38(3):554-567.
Celiac Disease and Malabsorption, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use